AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> High Profile ‘Global Leaders Group’ To Tackle Worldwide Threat Of Drug Resistant Pathogens 20/11/2020 Madeleine Hoecklin In a bid to step up a battle against other emerging and untreatable pathogens that could wreak havoc on the world in ways similar to COVID-19, WHO on Friday announced the launch of a One Health Global Leaders Group on Antimicrobial Resistance (AMR). The group, led by the prime ministers of Bangladesh and Barbados, aims […] Continue reading -> A New Era In The Fight Against Antimicrobial Resistance – Can We Revert The Silent Tsunami? 20/11/2020 Neda Milevska This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading -> WHO Recommends Against Remdesivir Use – ‘No Evidence’ It Improves Patient Outcomes 20/11/2020 J Hacker WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading -> ‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> High Profile ‘Global Leaders Group’ To Tackle Worldwide Threat Of Drug Resistant Pathogens 20/11/2020 Madeleine Hoecklin In a bid to step up a battle against other emerging and untreatable pathogens that could wreak havoc on the world in ways similar to COVID-19, WHO on Friday announced the launch of a One Health Global Leaders Group on Antimicrobial Resistance (AMR). The group, led by the prime ministers of Bangladesh and Barbados, aims […] Continue reading -> A New Era In The Fight Against Antimicrobial Resistance – Can We Revert The Silent Tsunami? 20/11/2020 Neda Milevska This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading -> WHO Recommends Against Remdesivir Use – ‘No Evidence’ It Improves Patient Outcomes 20/11/2020 J Hacker WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading -> ‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
High Profile ‘Global Leaders Group’ To Tackle Worldwide Threat Of Drug Resistant Pathogens 20/11/2020 Madeleine Hoecklin In a bid to step up a battle against other emerging and untreatable pathogens that could wreak havoc on the world in ways similar to COVID-19, WHO on Friday announced the launch of a One Health Global Leaders Group on Antimicrobial Resistance (AMR). The group, led by the prime ministers of Bangladesh and Barbados, aims […] Continue reading -> A New Era In The Fight Against Antimicrobial Resistance – Can We Revert The Silent Tsunami? 20/11/2020 Neda Milevska This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading -> WHO Recommends Against Remdesivir Use – ‘No Evidence’ It Improves Patient Outcomes 20/11/2020 J Hacker WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading -> ‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
A New Era In The Fight Against Antimicrobial Resistance – Can We Revert The Silent Tsunami? 20/11/2020 Neda Milevska This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading -> WHO Recommends Against Remdesivir Use – ‘No Evidence’ It Improves Patient Outcomes 20/11/2020 J Hacker WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading -> ‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Against Remdesivir Use – ‘No Evidence’ It Improves Patient Outcomes 20/11/2020 J Hacker WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading -> ‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
‘Tier System’ Encouraged By WHO To Prevent National Lockdowns 19/11/2020 Madeleine Hoecklin A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
Partnerships Between Public And Private Health Needed To Achieve Universal Heatlh Coverage 19/11/2020 Geoffrey Kamadi The COVID-19 pandemic did not so much create cracks in healthcare systems around the world, as it exposed weaknesses in them, participants at the Geneva Health Forum said Wednesday at a session on how health systems have fared during the COVID-19 pandemic. “We have found fragility everywhere,” said Edward Kelley, Director of Integrated Health Services […] Continue reading -> Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
Expanding Social Health Protection To Reach Universal Health Coverage 19/11/2020 Pip Cook/Geneva Solutions Experts met at the Geneva Health Forum (GHF) this week to discuss the successes and challenges met in expanding social health protection to achieve Universal Health Coverage (UHC). Every year, around 100 million people are pushed into “extreme poverty” because they have to pay for health care, and over 800 million people – almost 12% […] Continue reading -> How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts
How Can “Open Innovation” Support Research On Infectious Diseases? 18/11/2020 Geoffrey Kamadi Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading -> Posts navigation Older postsNewer posts